TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›HCWC
HCWC logo

HCWC

HEALTHY CHOICE WELLNESS CORP.

Next earnings Aug 12, 2026 · consensus $-0.04 EPS, $22.7M rev

Avoid
$0.21
▲ +10.05%
$0.21▼ -49.54%
over 1Y
L $0.19H $0.93
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+10.1%
1W+10.2%
1M-40.2%
3M-14.9%
YTD-26.4%
1Y-49.5%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Avoid
Quality
C-
Valuation
Fair value
Filings
Flagged
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Buy

Going-concern doubt, negative working capital and 115% dilution make this sub-$5M organic-food micro-cap uninvestable despite a 0.1x P/S.

Revenue $78.2M · FY2025

HCWC is a 19-store natural/organic grocery chain spun out of HCMC in September 2024, and the headline 12.7% revenue growth to $78.2M is almost entirely bought, not earned: management states the GreenAcres acquisition contributed ~$7.8M of the $8.8M increase, leaving just $1.0M of same-store sales growth. Beneath that, the business still does not make money — operating income was -$2.48M (worsening 39.8% YoY as SG&A rose $4.1M) and the company posted a -$3.94M net loss. Losses are narrowing (-$9.93M → -$4.51M → -$3.94M) and the 39.2% gross margin is genuinely strong for grocery, but three years into existence this is a structurally unprofitable retailer carrying standalone public-company costs.

The balance sheet is where the thesis breaks. MD&A explicitly flags 'net losses and negative working capital' and says cost-reduction initiatives and a 'committed equity financing' are 'critical to continuing as a going concern.' The numbers confirm it: $3.02M of cash against $12.7M current liabilities, current assets of only $9.98M (negative working capital of ~$2.7M), liabilities/equity of 3.59x, and $2.20M of debt now current. The rescue plan is equity issuance — and shares already ballooned 115.3% in a single year, so existing holders should expect further heavy dilution at a $0.21 price where the entire company is worth $4.71M.

Is HCWC a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Bear put spread (caution)~60d expiry
  • Long put 0 @ ~0.00 est
  • Short put 0 @ ~0.00 est
debit $0max +$0max $0

AVOID means we wouldn't engage at all — if expressing the short side anyway, only with capped risk.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY23FY24FY25
Revenue$55.7M$69.4M$78.2M
Gross profit$20.3M$27.1M$30.7M
Operating income-$10.5M-$1.78M-$2.48M
Net income-$9.93M-$4.51M-$3.94M
Diluted EPS-$1.08-$0.48-$0.24
Net margin-17.8%-6.5%-5.0%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$10.9M
EV / EBITDA—
EV / Sales0.1
EV / FCF16.1
P / FCF8.1
PEG (trailing)—
Earnings yield-71.5%
FCF yield12.3%

Quality & risk

ROIC (est.)-12.5%
Free cash flow$675K
Total debt$8.38M
Net cash-$5.36M
Altman Z-Score1.92 grey
Piotroski F-Score6/9

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+115.3%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has skewed negative — read the flagged items.
  1. 8-K Material agreement2026-06-03

    Entered new material definitive agreement (financing/supply); terms filed as exhibits

  2. 8-K Material agreement2026-05-29

    Signed another material agreement; details in exhibits, no financial impact quantified

  3. 10-Q Quarterly report2026-05-15

    Q1'26 results amid ongoing losses and going-concern reliance on equity financing

  4. 10-K Annual report2026-03-16

    FY25 sales +12.7% to $78.2M, loss narrowed, but going-concern doubt + material weakness

  5. 8-K Material agreement2026-02-17

    New agreement plus unregistered stock sale — added dilution to fund operations

  6. 8-K Shareholder vote2026-01-30

    Reported annual-meeting voting results; routine governance, no operational change

  7. DEF 14A Proxy statement2025-12-11

    Annual proxy — director elections and routine approvals, no business change

  8. 8-K Material agreement2025-11-14

    Financing deal with unregistered shares, charter change and modified shareholder rights

  9. S-3 Shelf registration (potential raise)2025-11-04

    Filed shelf registration enabling future securities sales — dilution overhang

Recent filings

all on EDGAR ↗
PRER14AFiling2026-06-24open ↗SCHEDULE 13D/AFiling2026-06-09open ↗SCHEDULE 13D/AFiling2026-06-09open ↗4Period ending 2026-06-022026-06-04open ↗4Period ending 2026-06-022026-06-04open ↗4Period ending 2026-06-022026-06-04open ↗4Period ending 2026-06-022026-06-04open ↗4Period ending 2026-06-022026-06-04open ↗4Period ending 2026-06-022026-06-04open ↗8-KPeriod ending 2026-05-282026-06-03open ↗PREM14APeriod ending 2026-05-292026-05-29open ↗8-KPeriod ending 2026-05-272026-05-29open ↗

Quality score

C-
ValueGrowthProfitHealthMom.
ValueA+
GrowthA-
ProfitabilityF
Financial healthC-
MomentumF
  • ✓Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✗Liabilities below 2× equity
0.1952-week0.93
Revenue
$78.2M
+12.7% YoY
Net margin
-5.0%
ROE
-53.9%
P/E
—

SEC fundamentals · FY 2025

'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$78.2M+12.7%
Net income-$3.94M+12.7%
Gross profit$30.7M+13.3%
Operating income-$2.48M-39.8%
Diluted EPS-$0.24+50.0%
Cash & equivalents$3.02M+46.8%
Total assets$33.5M-1.8%
Total liabilities$26.2M-17.5%
Stockholders' equity$7.31M+206.9%
Gross: 39.2%Op.: -3.2%L/E: 3.59x

Frequently asked

Is HEALTHY CHOICE WELLNESS CORP. (HCWC) a buy?
HCWC currently carries a Avoid rating with 4/5 conviction, derived from its latest SEC filings. Going-concern doubt, negative working capital and 115% dilution make this sub-$5M organic-food micro-cap uninvestable despite a 0.1x P/S.
What is HEALTHY CHOICE WELLNESS CORP.'s quality score?
HCWC scores 54.4058701545393/100 (grade C-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001948864, latest 10-Q filed 2026-05-15) · EODHD · Proprietary analysis · as of 7/4/2026, 9:57:46 AM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 5:57 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-06-02
Santi Christopher
President
Award815K
2026-06-02
Ollet John
Chief Financial Officer
Award815K
2026-06-02
Myers Behnam
Director
Award238K
2026-06-02
Lerman Michael Stuart
Director
Award238K
2026-06-02
Holman Jeffrey Elliot
Chief Executive Officer
Award1.29M
2026-06-02
Bodzin Gary
Director
Award238K
2026-05-25
Santi Christopher
President
Award73.6K
2026-05-25
Ollet John
Chief Financial Officer
Award73.6K

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score54 vs 67
Revenue growth12.7% vs 7.5%
Net margin-5.0% vs 10.0%
Return on equity-53.9% vs 12.0%
P/E— vs 26.2